Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation.

Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al-Najjar A, Marliere JF, Lebranchu Y, Baron C.

J Med Genet. 2010 Jan;47(1):54-8. doi: 10.1136/jmg.2009.068841. Epub 2009 Jul 5.

PMID:
19581275
2.

Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation.

Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al Najjar A, Boulanger MD, Houssaini TS, Marliere JF, Lebranchu Y, Baron C.

Transplantation. 2008 May 27;85(10):1406-11. doi: 10.1097/TP.0b013e31816c7dc7.

PMID:
18497679
3.

Impact of a polymorphism in the IL-12p40 gene on the outcome of kidney transplantation.

Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Al-Najjar A, Marliere JF, Lebranchu Y, Baron C.

Transplant Proc. 2009 Mar;41(2):654-6. doi: 10.1016/j.transproceed.2008.12.002.

PMID:
19328947
4.

PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.

Sester U, Presser D, Dirks J, Gärtner BC, Köhler H, Sester M.

Am J Transplant. 2008 Jul;8(7):1486-97. doi: 10.1111/j.1600-6143.2008.02279.x.

5.

The influence of innate immunity gene receptors polymorphisms in renal transplant infections.

Cervera C, Lozano F, Saval N, Gimferrer I, Ibañez A, Suárez B, Linares L, Cofán F, Ricart MJ, Esforzado N, Marcos MA, Pumarola T, Oppenheimer F, Campistol JM, Moreno A.

Transplantation. 2007 Jun 15;83(11):1493-500.

PMID:
17565323
6.

Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.

Pouteil-Noble C, Ecochard R, Bosshard S, Lacavalerie B, Donia A, Landrivon G, Tardy JC, Dubernard JM, Aymard M, Touraine JL.

Transpl Int. 1992;5 Suppl 1:S26-9.

PMID:
14621724
7.

HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.

Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.

Nephrol Dial Transplant. 2008 Aug;23(8):2673-8. doi: 10.1093/ndt/gfn111. Epub 2008 Mar 10.

PMID:
18332066
8.

Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation.

de Rooij BJ, van der Beek MT, van Hoek B, Vossen AC, Rogier Ten Hove W, Roos A, Schaapherder AF, Porte RJ, van der Reijden JJ, Coenraad MJ, Hommes DW, Verspaget HW.

J Hepatol. 2011 Oct;55(4):800-7. doi: 10.1016/j.jhep.2011.01.039. Epub 2011 Feb 18.

PMID:
21334396
9.

Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.

Jin ZK, Xu CX, Tian PX, Xue WJ, Ding XM, Zheng J, Ding CG, Ge GQ, Mao TC, Lin Y.

Transpl Immunol. 2012 Oct;27(2-3):69-74. doi: 10.1016/j.trim.2012.06.008. Epub 2012 Jun 30.

PMID:
22750489
10.

Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantation.

Robinson LG, Hilinski J, Graham F, Hymes L, Beck-Sague CM, Hsia J, Nesheim SR.

Pediatr Transplant. 2002 Apr;6(2):111-8.

PMID:
12000465
11.

Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.

Fan J, Meng XQ, Yang MF, Zhou L, Chen XM, Hu MJ, Fan WW, Ma WH, Li LJ.

Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):34-8.

12.

Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation.

Cervera C, Lozano F, Linares L, Antón A, Balderramo D, Suárez B, Pascal M, Sanclemente G, Cofán F, Ricart MJ, Navasa M, Roig E, Marcos MA, Pumarola T, Moreno A.

Transplant Proc. 2009 Jul-Aug;41(6):2259-61. doi: 10.1016/j.transproceed.2009.06.056.

PMID:
19715891
13.

Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.

Taherimahmoudi M, Ahmadi H, Baradaran N, Montaser-Kouhsari L, Salem S, Mehrsai A, Kalantar E, Jahani Y, Pourmand G.

Transplant Proc. 2009 Sep;41(7):2841-4. doi: 10.1016/j.transproceed.2009.07.027.

PMID:
19765452
14.

Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.

Toupance O, Bouedjoro-Camus MC, Carquin J, Novella JL, Lavaud S, Wynckel A, Jolly D, Chanard J.

Transpl Int. 2000;13(6):413-9.

PMID:
11140239
15.

Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients.

Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ.

Transplantation. 1999 Dec 27;68(12):1879-83.

PMID:
10628768
16.

Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.

Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L; Euro-SPK Study Group.

Nephrol Dial Transplant. 2005 May;20 Suppl 2:ii25-ii32, ii62.

PMID:
15814546
17.

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.

Flechner SM, Avery RK, Fisher R, Mastroianni BA, Papajcik DA, O'Malley KJ, Goormastic M, Goldfarb DA, Modlin CS, Novick AC.

Transplantation. 1998 Dec 27;66(12):1682-8.

PMID:
9884259
18.

24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.

Doyle AM, Warburton KM, Goral S, Blumberg E, Grossman RA, Bloom RD.

Transplantation. 2006 Apr 27;81(8):1106-11.

PMID:
16641594
19.

The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.

Reischig T, Jindra P, Svecová M, Kormunda S, Opatrný K Jr, Treska V.

J Clin Virol. 2006 Jun;36(2):146-51. Epub 2006 Mar 13.

PMID:
16531113
20.

Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection.

DesJardin JA, Gibbons L, Cho E, Supran SE, Falagas ME, Werner BG, Snydman DR.

J Infect Dis. 1998 Dec;178(6):1783-6.

PMID:
9815234

Supplemental Content

Support Center